Rottapharm | Madaus

arrowTo report an adverse event

arrowFor any other medical emergency or R&D questions


Choose site

Rottapharm | Madaus
is now part of Meda AB

Ultime notizie dal mondo R|M

Meda's acquisition of Rottapharm | Madaus is completed

Oct 10, 2014
Meda today announced the successful completion of its transaction to acquire Rottapharm | Madaus.
Dear customers: please continue to work with your existing Rottapharm | Madaus contacts for questions regarding products.
For more details regarding Meda, its operations and the Rottapharm Madaus transaction, please go to:

Notizie da R|M
Area istituzionale

Rottapharm’s long history of success began in 1961 with the creation of a small laboratory of independent research. From then on, the company has always invested on research, innovation, development and distribution on a world scale of new products mainly in the field of pharmaceutics and, in the following years, also in the fields of parapharmaceutics and nutraceutics. After acquiring the German multinational Madaus Pharma, the Group is currently one the most important pharmaceutical companies in Italy and is also present in over 85 countries worldwide.

Indice dell'area

As a leading player in the global healthcare landscape, Rottapharm | Madaus works to improve people life: with a strong research activity first, but also with campaigns for health and prevention awareness, educational projects, promotion of art and culture, support for non-profit humanitarian associations and with a continuous attention to children needs.
Discover all the initiatives promoted by Rottapharm|Madaus »

Indice dell'area